Related Experiment Video
Updated: Aug 15, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Tissue- and transformation-specific phosphotyrosyl proteins in v-erbB-transformed cells
M J McManus1, D C Connolly, N J Maihle
1Department of Pediatric and Adolescent Medicine, Mayo Foundation, Rochester, Minnesota 55905, USA.
Abstract:
To understand the mechanism of tissue-specific and transformation-specific signaling by the v-ErbB oncoprotein, we have investigated signaling pathways downstream of this transmembrane tyrosine kinase. In this report, we describe tissue-specific patterns of phosphotyrosyl proteins in three distinct cell types transformed by the v-erbB oncogene: fibroblasts, erythroblasts, and endothelial cells. In addition, we describe transformation-specific tyrosine phosphorylation events and signal complex formation in v-erbB-transformed fibroblasts. Two patterns of phosphotyrosyl proteins have been detected in v-erbB-transformed cells. The first is a fibroblast-specific pattern which includes unique phosphotyrosyl proteins of 170 kDa (c-ErbB1), 158 kDa, and 120 kDa (the catenin-like protein p120cas). The second is an erythroblast/endothelial cell-specific pattern which includes a prominent unidentified phosphotyrosyl protein of 120 kDa. Evaluation of the phosphotyrosyl proteins p120cas and SHC in chicken embryo fibroblasts infected with transforming and nontransforming v-erbB mutants reveals transformation-specific patterns of tyrosine phosphorylation. One corollary of these phosphorylation events in v-erbB-transformed fibroblasts is the formation of a complex involving SHC, growth factor receptor-bound protein 2, and a novel 75-kDa phosphotyrosyl protein. The results of these studies suggest that the v-ErbB oncoprotein can couple to multiple signal transduction pathways, that these pathways are tissue specific, and that v-erbB-mediated transformation involves specific tyrosine phosphorylation events.
Insights
The v-ErbB oncoprotein triggers distinct signaling pathways in different cell types, revealing tissue-specific and transformation-specific tyrosine phosphorylation patterns crucial for cell growth.
Area of Science:
- Oncogenic signaling
- Cellular transformation
- Tyrosine kinase pathways
Background:
- The v-ErbB oncoprotein, a transmembrane tyrosine kinase, drives cellular transformation.
- Understanding its signaling mechanisms is key to deciphering tissue-specific and transformation-specific effects.
Purpose of the Study:
- Investigate signaling pathways downstream of v-ErbB.
- Characterize tissue-specific phosphotyrosyl protein patterns in transformed cells.
- Identify transformation-specific tyrosine phosphorylation events and signal complex formation.
Main Methods:
- Analysis of phosphotyrosyl proteins in v-ErbB-transformed fibroblasts, erythroblasts, and endothelial cells.
- Evaluation of specific phosphotyrosyl proteins (p120cas, SHC) in chicken embryo fibroblasts infected with v-ErbB mutants.
- Detection of signal complex formation.
Main Results:
- Identified two distinct patterns of phosphotyrosyl proteins: fibroblast-specific (including c-ErbB1, p158, p120cas) and erythroblast/endothelial cell-specific (including a 120 kDa protein).
- Observed transformation-specific tyrosine phosphorylation patterns for p120cas and SHC in fibroblasts.
- Demonstrated the formation of a signal complex involving SHC, growth factor receptor-bound protein 2, and a 75 kDa protein in v-ErbB-transformed fibroblasts.
Conclusions:
- The v-ErbB oncoprotein engages multiple, tissue-specific signal transduction pathways.
- Specific tyrosine phosphorylation events are integral to v-ErbB-mediated cellular transformation.
- These findings elucidate the complex signaling network regulated by the v-ErbB oncoprotein.
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Tyrosine Kinases
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

